SG11202112479UA - Methods and compositions comprising staphylococcus protein a (spa) variants - Google Patents

Methods and compositions comprising staphylococcus protein a (spa) variants

Info

Publication number
SG11202112479UA
SG11202112479UA SG11202112479UA SG11202112479UA SG11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA SG 11202112479U A SG11202112479U A SG 11202112479UA
Authority
SG
Singapore
Prior art keywords
spa
variants
compositions
methods
staphylococcus protein
Prior art date
Application number
SG11202112479UA
Inventor
Olaf Schneewind
Dominique Missiakas
Yan Sun
Hwan Keun Kim
Miaomiao Shi
Xinhai Chen
Original Assignee
Univ Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chicago filed Critical Univ Chicago
Publication of SG11202112479UA publication Critical patent/SG11202112479UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202112479UA 2019-05-14 2020-05-13 Methods and compositions comprising staphylococcus protein a (spa) variants SG11202112479UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962847832P 2019-05-14 2019-05-14
PCT/US2020/070048 WO2020232471A2 (en) 2019-05-14 2020-05-13 Methods and compositions comprising staphylococcus protein a (spa) variants

Publications (1)

Publication Number Publication Date
SG11202112479UA true SG11202112479UA (en) 2021-12-30

Family

ID=73288805

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202112479UA SG11202112479UA (en) 2019-05-14 2020-05-13 Methods and compositions comprising staphylococcus protein a (spa) variants

Country Status (14)

Country Link
US (1) US20220323563A1 (en)
EP (1) EP3969031A4 (en)
JP (1) JP2022533096A (en)
KR (1) KR20220025724A (en)
CN (1) CN114340652A (en)
AU (1) AU2020273471A1 (en)
BR (1) BR112021022902A2 (en)
CA (1) CA3139981A1 (en)
CL (1) CL2021002992A1 (en)
CO (1) CO2021015337A2 (en)
IL (1) IL288060A (en)
MX (1) MX2021013833A (en)
SG (1) SG11202112479UA (en)
WO (1) WO2020232471A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114315996B (en) * 2021-12-31 2023-01-17 博格隆(浙江)生物技术有限公司 Preparation method of recombinant ProteinA protein and affinity chromatography medium

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184184A1 (en) * 2010-03-24 2012-10-30 Kaneka Corp Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand
CN103037885B (en) * 2010-07-02 2015-08-26 芝加哥大学 The composition relevant to albumin A (SpA) variant and method
EP2690173B1 (en) * 2011-03-25 2019-07-03 Kaneka Corporation Protein for affinity-separation matrix
US20160074497A1 (en) * 2013-05-03 2016-03-17 The University Of Chicago Staphylococcus live cell vaccines
KR20170137111A (en) * 2015-04-17 2017-12-12 알사니스 바이오사이언시스 게엠베하 s. Antibodies directed against immunoglobulin binding proteins of Aureus

Also Published As

Publication number Publication date
WO2020232471A2 (en) 2020-11-19
IL288060A (en) 2022-01-01
EP3969031A2 (en) 2022-03-23
CL2021002992A1 (en) 2022-07-08
CA3139981A1 (en) 2020-11-19
EP3969031A4 (en) 2023-10-25
AU2020273471A1 (en) 2021-12-23
JP2022533096A (en) 2022-07-21
WO2020232471A3 (en) 2020-12-30
US20220323563A1 (en) 2022-10-13
CN114340652A (en) 2022-04-12
BR112021022902A2 (en) 2022-01-25
MX2021013833A (en) 2022-03-17
KR20220025724A (en) 2022-03-03
CO2021015337A2 (en) 2022-02-17

Similar Documents

Publication Publication Date Title
GB201909190D0 (en) Therapeutic agents
GB201909194D0 (en) Therapeutic agents
GB201909191D0 (en) Therapeutic agents
EP3985014A4 (en) Romo1-derived antimicrobial peptides and variants thereof
ZA202100859B (en) Recombinant protein variants
SG10202011314SA (en) Game system
DK3737402T3 (en) Modificeret protein
GB201902277D0 (en) Therapeutic agents
AU201814954S (en) Game timer
EP4013445A4 (en) Therapeutic protein compositions and methods
EP3898960A4 (en) Human alpha-galactosidase variants
GB2587214B (en) Construction toy
GB201906804D0 (en) Therapeutic agents
IL288060A (en) Methods and compositions comprising staphylococcus protein a (spa) variants
GB202204938D0 (en) Compounds comprising curcmin and basic amino acids
SG11202109418QA (en) Synergistic insecticidal combinations
EP3747515C0 (en) Game device
EP3862059C0 (en) Modular game
GB201806760D0 (en) Puzzle
GB2601975B (en) Game court
CA206036S (en) Trickshot game
CA198206S (en) Gameboard
CA188912S (en) Puzzle piece
GB202101825D0 (en) Protein
GB202101826D0 (en) Protein